We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Kanjinti

News List

MVASI, KANJINTI Now Available in United States americanpharmaceuticalreview
July 22, 2019
Amgen and Allergan announced that MVASI™ (bevacizumab-awwb), a biosimilar to Avastin® (bevacizumab), and KANJINTITM (trastuzumab-anns), a biosimilar to Herceptin® (trastuzumab), are now available in the United States.
FDA Approves KANJINTI americanpharmaceuticalreview
June 20, 2019
Amgen and Allergan announced the U.S. Food and Drug Administration (FDA) has approved KANJINTI™ (trastuzumab-anns) for all approved indications of the reference product ...
FDA Approves Kanjinti (trastuzumab-anns), a Biosimilar to Herceptin drugs
June 17, 2019
FDA Approves Kanjinti.